Experts from BRG recently discussed the two presidential candidates' stances on key healthcare issues, including drug pricing ...

Mental health platform Headspace launched a new feature last week called Ebb, an empathetic AI companion, to help people process their emotions. Santa Monica, California-based Headspace offers an ...

Yet another Bay Area healthcare AI startup was born this week. On Tuesday, San Francisco-based generative AI voice platform Parakeet Health formally launched and announced $3 million in seed funding.

Suki, a company offering AI voice solutions to healthcare companies, has secured $70 million in Series D funding, it announced Thursday. The financing will help the company build new products.

A MeiraGTx Holdings gene therapy for Parkinson’s disease has preliminary data from a small clinical trial showing the one-time treatment showed both safety and efficacy, results that lay the ...

Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of the chronic respiratory condition. Upstream Bio is pursuing a ...

Rural Americans have long experienced poorer health outcomes compared to their urban counterparts. New evidence shows that the divide is widening, with rural adults aged 25 to 54 significantly ...

Big data analysis is an invaluable resource in healthcare and life sciences. Data can tell a pharmaceutical company which drugs a medical specialist prescribes and where they are based. This ...

Bipartisan Congressional scrutiny has shone a harsh spotlight on the many tactics used by pharmacy benefit managers (PBMs) and Big Pharma that contribute to the sky high costs of prescription ...

The 2024 election is nearing the corner and has major implications for the healthcare industry, from abortion to drug pricing. During the Reuters Total Health Conference held in Chicago on Tuesday ...

The conundrum of American health care has become all too familiar: While spending outpaces other high-income countries, our quality of care often lags our peers – demonstrating no real ...

Shortly after releasing a scathing interim report in July that revealed how three players dominate the pharmacy benefit manager market and raise drug costs for patients, the Federal Trade ...